Vilazodone Hydrochloride Tablet
Product Images NDC 16729-353

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Vilazodone Hydrochloride (NDC 16729-353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vilazodone Hydrochloride 10 mg-30 Tablets (Label)

Label for Vilazodone Hydrochloride Tablets 10 mg, oral film-coated tablets in a package of 30 tablets. The label includes NDC 16729-352-10, storage instructions, and manufacturing details by Intas Pharmaceuticals Limited for Accord Healthcare Inc. It instructs to dispense with a medication guide and lists the package size and dosage form.*

FDA Label Image

Vilazodone Hydrochloride 20 mg-30 Tablets (Label)

Vilazodone Hydrochloride 20 mg tablets label from Accord Healthcare Inc. The label indicates oral tablet dosage form, contains 30 tablets per package, and includes directions to dispense the accompanying medication guide. Storage instructions and manufacturer details (Intas Pharmaceuticals Limited, India) are also present. Two barcodes and space for a varnish-free area are visible.*

FDA Label Image

Vilazodone Hydrochloride 40 mg-30 Tablets (Label)

Vilazodone Hydrochloride Tablets 40 mg oral tablets packaging label. The label shows dosage strength, quantity of 30 tablets, manufacturer Accord Healthcare Inc., and a reminder to pharmacists to dispense the Medication Guide. Storage information and manufacturer details from India are also included.*

FDA Label Image

Figure 1. Effect Of Other Drugs On Vilazodone Pharmacokinetics (Vilazodone Hydrochloride Figure 1)

A forest plot chart depicting the fold change and 90% confidence intervals (CI) for pharmacokinetic (PK) parameters Cmax and AUC of Vilazodone Hydrochloride in the presence of different substances: ethanol, CYP3A4 inhibitors (ketoconazole), CYP3A4 inducers (carbamazepine), and proton pump inhibitors (pantoprazole). The x-axis shows change relative to reference from 0.5 to 2.0.*

FDA Label Image

Figure 2. Impact Of Vilazodone On Other Drug Pharmacokinetics (Vilazodone Hydrochloride Figure 2)

A forest plot showing the fold change and 90% confidence intervals for various substrate changes relative to reference values. Substrates include CYP3A4 (Nifedipine), CYP1A2 (Caffeine), CYP2D6 (Debrisoquine), CYP2C9 (Flurbiprofen), CYP2C19 (Mephenytoin), and P-gp (Digoxin), with pharmacokinetic parameters such as AUCp, CRmp, URmp, CLrm, Um, and Cmax plotted along a horizontal axis representing change relative to reference from 0.5 to 2.0.*

FDA Label Image

Figure 3. Impact Of Intrinsic Factors On Vilazodone Pharmacokinetics (Vilazodone Hydrochloride Figure 3)

A forest plot illustrating pharmacokinetic (PK) parameters Cmax and AUC fold changes with 90% confidence intervals. The chart compares these metrics across population subgroups based on age (>65 years), gender (females), renal impairment (mild, moderate, severe), and hepatic impairment (mild, moderate, severe), with a reference change value of 1.0 on the x-axis.*

FDA Label Image

Vilazodone Hydrochloride Structural Formula (Vilazodone Hydrochloride Structure)

Chemical structure of Vilazodone Hydrochloride, showing the molecular arrangement used in the pharmaceutical product by Accord Healthcare Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.